Pharmaceutical Middlemen Feel the Squeeze

Lawmakers and the Trump administration are focusing on insurers and pharmacy benefit managers in their push for drug-price transparency.

Health and Human Services Secretary Alex Azar at the National Governors Association winter meeting on Feb. 24 in Washington.
AP Photo/Jose Luis Magana

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.